Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Blackfinch Investments (Fund)
Blackfinch Ventures EIS Portfolios
2nd Dec 2024
Calculus Capital (Funds)
Calculus Knowledge Intensive EIS Fund 3
29th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
107: Legal dos and don’ts of EIS and VCTs | Tom Wilde of Shoosmiths
Stay up-to-date with the latest research
Sign up to our newsletter
Latest Corporate research
Our research can be accessed for free under MIFID.
Find out more >
All Corporate research
- Update
- Monthly Report
- Sector Report
- Initiation
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
list companies
genedrive Plc
Life Sciences
Hepatitis C market frustrations
18 Jul 2019
The 600 Group
Industrial
Transformation provides strong growth potential
By
Paul Singer
18 Jul 2019
Stay up-to-date with the latest research
Sign up to our newsletter
Redx Pharma
Life Sciences
Phase I trial resumed
10 Jul 2019
Burford Capital
Financials
Petersen appeals to investors
By
Dr Brian Moretta
09 Jul 2019
Building & Construction
UK Housebuilding Sector in 2Q 2019
05 Jul 2019
Arbuthnot Banking Group Plc
Financials
Mortgage portfolio acquisitions
By
Mark Thomas
03 Jul 2019
The Monthly: July 2019
02 Jul 2019
RM Secured Direct Lending
Financials
July 2019 Monthly
02 Jul 2019
The 600 Group
Industrial
Acquisition of CMS attractive and EPS-enhancing
By
Paul Singer
02 Jul 2019
Allergy Therapeutics plc
Life Sciences
Successful legal outcome removes uncertainty
01 Jul 2019
Oxford BioMedica
Life Sciences
Eying up long-term value
01 Jul 2019
Prev
1
...
48
49
50
51
52
...
78
Next
